India’s vaccinations plummet as coronavirus infections soar

By Krishna N. Das

NEW DELHI (Reuters) -India’s daily COVID-19 shots have fallen sharply from an all-time high reached early last month as domestic companies struggle to boost supplies and imports are limited, even as the country fights the world’s worst surge in infections.

Daily inoculations have averaged 2.5 million since hitting a peak of 4.5 million on April 5. A quadrupling of coronavirus cases during the period has collapsed the public health system in many regions of the country.

India, with the world’s biggest vaccine making capacity, has partially or fully immunized only 12% of its 1.35 billion people, according to data from the government’s Co-Win.

Public forecasts by its only two current vaccine producers show their total monthly output of 70-80 million doses would increase only in two months or more, though the number of people eligible for vaccines has doubled to an estimated 800 million since May 1.

India on Saturday received 150,000 doses of Russia’s Sputnik V vaccine and the government said “millions of doses” more will come in.

Pfizer said on Monday it was in discussions with the Indian government seeking an “expedited approval pathway” for its vaccine.

“Unfortunately, our vaccine is not registered in India although our application was submitted months ago,” CEO Albert Bourla said.

“We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country.”

Pfizer was the first company to seek emergency use authorization for its vaccine in India late last year. It withdrew its application in February after the drugs regulator sought a small, local safety study for the shot before considering its request.

But as cases surged, India said last month it would fast-track approval for some foreign shots, with companies now required to do a local trial within 30 days of approval, not before.

GlobalData analyst Prashant Khadayate said Pfizer will become a “vaccine of choice among people who can afford it” but that its need to be stored in ultra-low temperatures would be a challenge.

India has also invited Johnson & Johnson and Moderna to sell their vaccines to the country.

(Reporting by Krishna N. Das; Additional reporting by Manash Mishra; Editing by Tom Hogue and Nick Macfie)

Exclusive: Biden set to ban most travel to U.S. from India to limit COVID-19 spread

By David Shepardson

WASHINGTON (Reuters) – U.S. President Joe Biden is expected to impose new travel restrictions on India starting Tuesday in light of the COVID-19 epidemic, barring most non-U.S. citizens from entering the United States, a White House official told Reuters.

The new restrictions are on the advice of the U.S. Centers for Disease Control and Prevention and are imposed “in light of extraordinarily high COVID-19 case loads and multiple variants circulating in India,” the official said. A formal announcement is expected on Friday and the policy will take effect on Tuesday, May 4 at 12:01 am ET (0401 GMT).

Biden in January issued a similar ban on most non-U.S. citizens entering the country who have recently been in South Africa. He also reimposed an entry ban on nearly all non-U.S. travelers who have been in Brazil, the United Kingdom, Ireland and 26 countries in Europe that allow travel across open borders.

The policy means most non-U.S. citizens who have been in one of those countries – and now India – within the last 14 days are not eligible to travel to the United States. China and Iran are also both covered by the policy.

Second only to the United States in total infections, India has reported more than 300,000 new cases daily for nine days in a row, hitting another global record of 386,452 on Friday.

Total deaths have surpassed 200,000 and cases are nearing 19 million – nearly 8 million since February alone – as virulent new strains have combined with “super-spreader” events such as political rallies and religious festivals.

Medical experts say real numbers may be five to 10 times higher than the official tally.

Other countries have imposed similar travel restrictions on India, including the United Kingdom, Germany, Italy and Singapore, while Canada, Hong Kong and New Zealand have suspended all commercial travel with India.

Permanent U.S. residents and family members and some other non-U.S. citizens are permitted to return to the United States under the order.

(Reporting by David Shepardson, Editing by Rosalba O’Brien)

India demand fears, weak Japan crude imports knock oil prices 2%

By Laila Kearney

NEW YORK (Reuters) – Oil prices were down 2% on Friday, falling from six-week highs as investors unloaded positions after weak Japanese crude import data and on worries about fuel demand in India, where COVID-19 infections have soared.

U.S. crude and global benchmark Brent were set for their biggest daily drops in about three weeks, but were still on track for monthly gains of about 8% and 6%, respectively. Fuel demand worldwide is mixed but consumption is rising in the United States and China.

Brent crude fell by $1.30, or 1.9%, at $67.26 a barrel by 12:48 p.m. EDT (1648 GMT), the last day of trading for the front-month June contract. U.S. West Texas Intermediate crude for June was at $63.67 a barrel, down $1.34, or 2.1%.

“The tug of war between summer demand growth prospects and worsening COVID infections is still in full swing,” JBC Energy analysts wrote on Friday.

India, the world’s third largest oil consumer, is in deep crisis, with hospitals and morgues overwhelmed, as the number of COVID-19 cases topped 18 million on Thursday.

Japan’s – another major crude oil importer – imports fell 25% in March from a year earlier to 2.34 million barrels per day, according to government figures. However, the country’s factory activity expanded at the fastest pace since early 2018.

“There are still several major countries struggling mightily with the COVID-19 and of course there is a humanitarian crisis developing in India,” said John Kilduff, partner at Again Capital. “These are two big sources of demand that are taking a hit.”

OPEC oil output rose in April due to more supply from Iran, countering the cartel’s pact with allies to reduce supply.

A Reuters survey forecast that Brent would average $64.17 in 2021, up from last month’s consensus of $63.12 per barrel and the $62.3 average for the benchmark so far this year.

(Additional reporting by Shadia Nasralla and Florence Tan; Editing by Kirsten Donovan and David Gregorio)

Exclusive: India’s oxygen crisis to ease by mid-May, output to jump 25% – executive

By Shivani Singh and Devjyot Ghoshal

NEW DELHI (Reuters) – India’s severe medical oxygen supply crisis is expected to ease by mid-May, a top industry executive told Reuters, with output rising by 25% and transport infrastructure ready to cope with a surge in demand caused by a dramatic rise in coronavirus cases.

Dozens of hospitals in cities such as New Delhi and Mumbai have run short of the gas this month, sending relatives of patients scrambling for oxygen cylinders, sometimes in vain.

Medical oxygen consumption in India has shot up more than eight-fold from usual levels to about 7,200 tonnes per day this month, said Moloy Banerjee of Linde Plc, the country’s biggest producer.

“This is what is causing the crisis because no one was prepared for it, particularly the steep curve up,” Banerjee, who heads the company’s South Asia gas business, told Reuters on Thursday.

Linde – whose two affiliates in the country are Linde India and Praxair India – and other suppliers are ramping up production to a total of more than 9,000 tonnes per day by the middle of next month, he said.

A logistics crisis impeding the speedy movement of oxygen from surplus regions in eastern India to hard-hit northern and western areas would also be resolved in the coming weeks as more distribution assets are deployed, Banerjee said.

“My expectation is that by the middle of May we will definitely have the transport infrastructure in place that allows us to service this demand across the country,” he said.

Banerjee said India was importing around 100 cryogenic containers to transport large quantities of liquid medical oxygen, with Linde providing 60 of those. Some are being flown in by Indian Air Force aircraft.

Many of these containers will be placed on dedicated trains that would cut across the country, each carrying between 80-160 tonnes of liquid oxygen and delivering to multiple cities.

The company is also looking to double the number of oxygen cylinders in its distribution network to at least 10,000, which would improve supply to rural areas with weak infrastructure.

“We are trying to create a hub-and-spoke type of system so that we make a lot of liquid oxygen available at the local area, from where the local dealers can pick it up,” Banerjee said.

India’s total COVID-19 cases passed 18 million on Thursday after another world record number of daily infections.

(Reporting by Shivani Singh and Devjyot Ghoshal; Editing by Krishna N. Das and Giles Elgood)

India infections top 18 million as gravediggers work round the clock

By Alasdair Pal and Francis Mascarenhas

NEW DELHI/MUMBAI (Reuters) -India’s total COVID-19 cases passed 18 million on Thursday after another world record number of daily infections, as gravediggers worked around the clock to bury victims and hundreds more were cremated in makeshift pyres in parks and parking lots.

India reported 379,257 new infections and 3,645 new deaths on Thursday, health ministry data showed, the highest number of fatalities in a single day since the start of the pandemic.

The world’s second most populous nation is in deep crisis, with hospitals and morgues overwhelmed.

Mumbai gravedigger Sayyed Munir Kamruddin, 52, said he and his colleagues were working non-stop to bury victims.

“I’m not scared of COVID, I’ve worked with courage. It’s all about courage, not about fear,” he said. “This is our only job. Getting the body, removing it from the ambulance, and then burying it.”

Each day, thousands of Indians search frantically for hospital beds and life-saving oxygen for sick relatives, using social media apps and personal contacts. Hospital beds that become available, especially in intensive care units (ICUs), are snapped up in minutes.

“The ferocity of the second wave took everyone by surprise,” K. Vijay Raghavan, principal scientific adviser to the government, was quoted as saying in the Indian Express newspaper.

“While we were all aware of second waves in other countries, we had vaccines at hand, and no indications from modelling exercises suggested the scale of the surge.”

India’s military has begun moving key supplies, such as oxygen, across the nation and will open its healthcare facilities to civilians.

Hotels and railway coaches have been converted into critical care facilities to make up for the shortage of hospital beds.

India’s best hope is to vaccinate its vast population, experts say, and on Wednesday it opened registration for all above the age of 18 to receive shots from Saturday.

But although it is the world’s biggest producer of vaccines, India does not have the stocks for the estimated 800 million now eligible.

Many who tried to sign up for vaccination said they failed, complaining on social media of being unable to get a slot or even to simply get on the website, as it repeatedly crashed.

“Statistics indicate that far from crashing or performing slowly, the system is performing without any glitches,” the government said on Wednesday.

More than 8 million people had registered, it said, but it was not immediately clear how many had got slots.

A local official in Mumbai said the city had paused its vaccination drive for three days as supplies were running short, while officials said the worst-hit state of Maharashtra was likely to extend strict coronavirus curbs by another two weeks.

DEATHS LIKELY UNDER-REPORTED

Only about 9% of India’s population of about 1.4 billion has received a dose since the vaccination campaign began in January.

However, while the second wave overwhelms the health system, the official death rate is below that of Brazil and the United States.

India has reported 147.2 deaths per million, the Reuters global COVID-19 tracker shows, while Brazil and the United States reported figures of 1,800 and 1,700 respectively.

However, medical experts believe India’s true COVID-19 numbers may be five to 10 times greater than the official tally.

At Delhi’s Holy Family Hospital, patients arrived in ambulances and private vehicles, some gasping for air as their oxygen cylinders ran out. In the ICU, patients lay on trolleys between beds.

“Someone that should be in the ICU is being treated in the wards,” Dr. Sumit Ray, head of the unit, told Reuters.

“We are completely full. The doctors and nurses are demoralized, they know they can do better, but they just don’t have the time. No one takes a break.”

The U.S. State Department issued a travel advisory on Wednesday against travel to India because of the pandemic and advised its citizens to leave the country.

Prime Minister Narendra Modi has been criticized for allowing massive political rallies and religious festivals which have been super-spreader events in recent weeks.

“The people of this country are entitled to a full and honest account of what led more than a billion people into a catastrophe,” Vikram Patel, a global health expert at Harvard Medical School, said in the Hindu newspaper.

AID STARTS ARRIVING

India expects close to 550 oxygen generating facilities from around the world as medical aid starts pouring in, Foreign Secretary Harsh Vardhan Shringla said on Thursday.

Two planes from Russia, carrying 20 oxygen concentrators, 75 ventilators, 150 bedside monitors, and 22 tonnes of medicine, have arrived in Delhi.

The United States is sending supplies worth more than $100 million, including 1,000 oxygen cylinders, 15 million N95 masks and 1 million rapid diagnostic tests, the White House said on Wednesday.

The supplies will begin arriving on Thursday, it added.

The United States also has redirected its own order of AstraZeneca manufacturing supplies to India, to allow it to make more than 20 million doses, the White House said.

India will receive a first batch of Russia’s Sputnik V vaccine on May 1. Russia’s RDIF sovereign wealth fund, which markets Sputnik V globally, has signed deals with five Indian manufacturers for more than 850 million vaccine doses a year.

Bangladesh said it would send about 10,000 vials of anti-viral medicines, 30,000 PPE kits, and several thousand mineral and vitamin tablets.

Germany will send 120 ventilators on Saturday, and a mobile oxygen production facility next week, its defense ministry said.

(Additional reporting by Shilpa Jamkhandikar in Mumbai, Anuron Kumar Mitra in Bengaluru, Neha Arora and Tanvi Mehta in Delhi, Ruma Paul in Dhaka, Subrata Nag Choudhury in Kolkata; Writing by Michael Perry and Giles Elgood; Editing by Raju Gopalakrishnan and Gareth Jones)

U.S. pledges sustained help for India in tackling COVID crisis

By Humeyra Pamuk and David Brunnstrom

WASHINGTON (Reuters) -Senior U.S. officials on Tuesday pledged sustained support for India in helping it deal with the world’s worst current surge of COVID-19 infections, warning the country is still at the “front end” of the crisis and overcoming it will take some time.

The White House’s National Security Council coordinator for the Indo-Pacific, Kurt Campbell, told a virtual event on the U.S. assistance that President Joe Biden had told Indian Prime Minister Narendra Modi on a phone call on Monday: “You let me know what you need and we will do it.”

Campbell said at the event, organized by the U.S.-India Business Council and U.S. Chamber of Commerce Foundation, that Washington was committed to helping the world’s second most populous country get to grips with the crisis.

“We all have to realize that this is not a challenge that is going to resolve (in) the next several days,” he said.

Tackling the crisis, he said, was important not just for the people of India but for the United States, given India’s essential role as global provider of vaccines.

India is now the epicenter of the global coronavirus pandemic as a second wave of infections has driven the death toll up to almost 200,000.

On Tuesday, vital medical supplies began to reach the country of 1.35 billion people but hospitals starved of life-saving oxygen and beds still were turning away coronavirus patients.

The United States and other countries pledged urgent medical aid to try to contain the emergency in India.

The U.S. State Department’s coordinator for global COVID-19 response, Gayle Smith, added: “We all need to understand that we are still at the front end of this. This hasn’t peaked yet.

“So this is going to require determination…We’re going to work really hard for some time, but we’re confident we can do it,” she said. “We anticipate that at the height of this kind of complex emergency, it’s going to be very fluid for a while as things fall into place. We are collectively going to have to be very agile and very nimble.”

Jeremy Konyndyk, global COVID-19 adviser for USAID, said the agency was concerned about the situation in countries in the same region as India and wanted to support both India’s capacity to get the situation under control and the wider region.

He said the United States was providing some badly needed raw materials to the Serum Institute of India to allow it to scale up the production of the AstraZeneca vaccine there.

Aside from the United States, countries including Britain and Germany have pledged support, while the World Health Organization said it was working to deliver 4,000 oxygen concentrators, calling India’s plight “beyond heartbreaking”.

Two Indian government sources told Reuters earlier on Tuesday that New Delhi expects to secure the biggest chunk of the 60 million AstraZeneca COVID-19 vaccine doses the United States will share globally.

On Monday, senior U.S. officials said an agreement between the United States and three of its closest Indo-Pacific partners to produce up to a billion coronavirus vaccine doses in India by the end of 2022 to supply other Asian countries were “still on track,” despite the current crisis in the country.

(Reporting by David Brunnstrom and Humeyra Pamuk; Editing by Mark Heinrich)

Vital medical supplies reach India as COVID deaths near 200,000

By Shilpa Jamkhandikar, Rupam Jain and Sanjeev Miglani

NEW DELHI (Reuters) – Vital medical supplies began to reach India on Tuesday as hospitals starved of life-saving oxygen and beds turned away coronavirus patients, and a surge in infections pushed the death toll close to 200,000.

A shipment from Britain, including 100 ventilators and 95 oxygen concentrators, arrived in the capital New Delhi, though a spokesman for Prime Minister Boris Johnson said Britain had no surplus COVID-19 vaccine doses to spare.

France is sending eight large oxygen-generating plants this week while Ireland, Germany and Australia are dispatching oxygen concentrators and ventilators, an Indian foreign ministry official said, underlining the crucial need for oxygen.

U.S. President Joe Biden reaffirmed U.S. commitment to helping India, saying he was expecting to send vaccines there while senior officials from his administration warned that the country was still at the “front end” of the crisis.

India’s first “Oxygen Express” train pulled into New Delhi, laden with about 70 tonnes of oxygen from an eastern state, but the crisis has not abated in the city of 20 million people at the epicenter of the world’s deadliest wave of infections.

“The current wave is extremely dangerous and contagious and the hospitals are overloaded,” said Delhi Chief Minister Arvind Kejriwal, adding that a large public area in the capital will be converted into a critical care hospital.

With frustration mounting, relatives of a recently deceased COVID-19 patient assaulted staff with knives at a hospital in the southeast of New Delhi, injuring at least one person, a hospital spokeswoman said.

A video posted on social media showed several people brawling with guards at the same hospital. Delhi High Court has advised local authorities to provide security at hospitals.

The World Health Organization said it was working to deliver 4,000 oxygen concentrators to India, where mass gatherings, more contagious variants of the virus and low vaccination rates have sparked the second major wave of contagion.

With vaccine demand outstripping supply in the country of 1.3 billion people, two U.S. drugmakers have offered support.

Gilead Sciences said on Monday it would give India at least 450,000 vials of its antiviral drug remdesivir. Merck & Co said on Tuesday it was partnering with five Indian generic drugmakers to expand production and access to its experimental COVID-19 drug molnupiravir.

India is also negotiating with the United States, which has said it will share 60 million doses of AstraZeneca’s COVID-19 vaccine with other countries. A senior official participating in the talks said Prime Minister Narendra Modi had been assured of priority for India.

Supply uncertainty could force Maharashtra, India’s hardest-hit state, to postpone inoculations for people aged between 18 and 45, a government official said.

Biden said he had spoken on Monday at length with Modi, including about when the United States would be able to ship vaccines to India, the world’s second most populous country, and said it was his clear intention to do so.

MOUNTING TOLL

India’s 323,144 new cases over the past 24 hours stood below a worldwide peak of 352,991 hit on Monday, and 2,771 new deaths took the toll to 197,894.

But the fewer confirmed infections were largely due to a drop in testing, according to health economist Rijo M John of the Indian Institute of Management in Kerala, a southern state.

“This should not be taken as an indication of falling cases, rather a matter of missing out on too many positive cases,” he said on Twitter.

The U.S. State Department’s coordinator for global COVID-19 response, Gayle Smith, warned India’s challenge will require a sustained effort: “We all need to understand that we are still at the front end of this. This hasn’t peaked yet.”

Dr. K. Preetham, an administrator at the Indian Spinal Injuries Centre, said patients there were having to share oxygen cylinders because of the oxygen shortage.

New Delhi is in lockdown, as are the southern state of Karnataka and Maharashtra, where the country’s financial capital Mumbai is situated.

An uneven patchwork of restrictions, complicated by local elections and mass gatherings such as the weeks-long Kumbh Mela, or pitcher festival, could trigger COVID-19 breakouts elsewhere.

About 20,000 devout Hindus gathered by the Ganges river in the northern city of Haridwar on the last auspicious day of the festival for a bath they believe will wash away their sins.

“We believe Mother Ganga will protect us,” said a woman on the riverbank, where people bathed with few signs of physical distancing measures.

India has turned to its armed forces for help with the pandemic. Even China, which is locked in a military standoff with India along their disputed Himalayan border, said it was trying to get medical supplies to its neighbour.

In some cities, bodies were being cremated in makeshift facilities in parks and parking lots. Television channels showed bodies crammed into an ambulance in the western city of Beed as modes of transport ran short.

SUPPLY UNCERTAINTY

India has converted hotels and railway coaches into critical care facilities to make up for the shortage of beds, but experts say the next crisis will be a lack of healthcare professionals.

Companies ranging from conglomerates such as Tata Group and Reliance Industries Ltd to Jindal Steel and Power have stepped forward to help supply medical oxygen.

The U.S. Chamber of Commerce has said India’s economy, the world’s sixth largest, could falter because of the spike in infections, creating a drag for the global economy.

Australia halted direct passenger flights from India until May 15, joining other nations taking steps to keep out more virulent variants of the virus.

India has an official tally of 17.64 million infections, but experts believe the real number runs much higher.

(Reporting by Anuron Kumar Mitra in Bengaluru, Rupam Jain and Shilpa Jamkhandikar in Mumbai, Amlan Chakraborty and Sanjeev Miglani in Delhi, Saurabh Sharma in Lucknow; additional reporting by Rajendra Jadhav in Satara and Sumit Khanna in Ahmedabad, Humeyra Pamuk, Steve Holland and David Brunnstrom in Washington; Writing by Himani Sarkar and Timothy Heritage; Editing by Clarence Fernandez and Mark Heinrich)

U.S. to share up to 60 million AstraZeneca vaccine doses globally: White House

By Andrea Shalal

WASHINGTON (Reuters) – The United States will start to share up to 60 million doses of AstraZeneca Plc’s coronavirus vaccine with other countries as soon as the next few weeks, the White House said on Monday.

White House Press Secretary Jen Psaki said the United States would release the doses to other countries as they become available.

She said there could be 10 million doses cleared for export “in coming weeks.” About 50 million more doses are currently being produced and could ship in May and June.

“Right now we have zero doses available of AstraZeneca,” Psaki said, noting that U.S. regulators still need to review the quality of those already produced.

Psaki said the Biden administration is still deciding what the process will be to determine where and how it will share the vaccine.

“We will consider a range of options from our partner countries and, of course, much of that will be through direct relationships,” she said.

The AstraZeneca vaccine has not yet been authorized for U.S. use by the Food and Drug Administration.

The Biden administration in March said it would send roughly 4 million doses of the British drugmaker’s vaccine to Canada and Mexico, and is under growing pressure now to expand sharing of its stockpile with India and other countries.

India has become the latest epicenter of the pandemic, threatening to overwhelm its healthcare system.

An AstraZeneca spokeswoman could not comment on specifics of the arrangement, but said the doses were part of its supply commitments to the U.S. government. “Decisions to send U.S. supply to other countries are made by the U.S. government,” she said.

The Associated Press earlier on Monday reported the doses would be shared in coming months following their clearance by the FDA.

The AP reported that the doses were made at the Emergent BioSolutions facility in Baltimore, which came under harsh criticism for a long list of cleanliness and manufacturing problems found during an FDA inspection.

AstraZeneca is no longer making vaccine at that plant after a batch of Johnson & Johnson’s vaccine was ruined by contamination with ingredients from the AstraZeneca shot.

J&J is now overseeing production of its vaccine at the Emergent plant.

(Additional reporting by Susan Heavey, Caroline Humer and Michael Erman; Editing by Tim Ahmann and Bill Berkrot)

India sends army to help hospitals hit by COVID-19 as countries promise aid

By Shilpa Jamkhandikar and Neha Arora

NEW DELHI (Reuters) – India ordered its armed forces on Monday to help tackle surging new coronavirus infections that are overwhelming hospitals, as countries including Britain, Germany and the United States pledged to send urgent medical aid. In a meeting with Prime Minister Narendra Modi, the Chief of Defense Staff General Bipin Rawat said oxygen would be released to hospitals from armed forces reserves and retired medical military personnel would join COVID-19 health facilities.

And where possible, military medical infrastructure will be made available to civilians, a government statement said, as new coronavirus infections hit a record peak for a fifth day.

“Air, Rail, Road & Sea; Heaven & earth are being moved to overcome challenges thrown up by this wave of COVID19,” Health Minister Harsh Vardhan said on Twitter.

Modi on Sunday urged all citizens to get vaccinated and to exercise caution amid what he called a “storm” of infections, while hospitals and doctors in some northern states posted urgent notices saying they were unable to cope with the influx.

In some of the worst-hit cities, bodies were being burnt in makeshift facilities offering mass cremations.

The southern state of Karnataka, home to the tech city of Bengaluru, ordered a 14-day lockdown from Tuesday, joining the western industrial state of Maharashtra, where lockdowns run until May 1, although some states were also set to lift lockdown measures this week.

The patchy curbs, complicated by local elections and mass festival gatherings, could prompt breakouts elsewhere, as infections rose by 352,991 in the last 24 hours, with crowded hospitals running out of oxygen supplies and beds.

“Currently the hospital is in beg-and-borrow mode and it is an extreme crisis situation,” said a spokesman for the Sir Ganga Ram Hospital in the capital, New Delhi.

FIRE

Following a fire at a hospital in the western diamond industry hub of Surat, five COVID-19 patients died after being moved to other hospitals that lacked space in their intensive care units, a municipal official told Reuters.

Television channel NDTV broadcast images of three health workers in the eastern state of Bihar pulling a body along the ground on its way to cremation, as stretchers ran short.

“If you’ve never been to a cremation, the smell of death never leaves you,” Vipin Narang, a political science professor at Massachusetts Institute of Technology (MIT) in the United States, said on Twitter.

“My heart breaks for all my friends and family in Delhi and India going through this hell.”

On Sunday, President Joe Biden said the United States would send raw materials for vaccines, medical equipment and protective gear. Germany joined a growing list of countries pledging supplies.

In Moscow, which expects 50 million doses of its Sputnik V vaccine to be made each month in India this summer, a Kremlin spokesman expressed concern over the situation.

India, with a population of 1.3 billion, has an official tally of 17.31 million infections and 195,123 deaths, after 2,812 deaths overnight, health ministry data showed, although health experts say the figures probably run higher.

The surge in infections hit oil prices amid worries about a fall in fuel demand in the world’s third-biggest oil importer.

RALLY BACKLASH

Several cities have ordered curfews, while police enforce social distancing and mask-wearing. Politicians, especially Modi, have faced criticism for holding rallies during state election campaigns that draw thousands into packed stadiums.

About 8.6 million voters were expected to cast ballots on Monday in the eastern state of West Bengal, in the final phases of a contest set to wrap up this week. Also voting in local elections was the most populous state of Uttar Pradesh, which has been reporting an average of 30,000 infections a day.

Modi’s plea on vaccinations came after inoculations peaked at 4.5 million doses on April 5, but have since averaged about 2.7 million a day, government figures show.

Virologists said more infectious variants of the virus, including an Indian one, have fueled the resurgence.

The government told people to stay indoors and follow hygiene protocols. “Please don’t invite people into your home… It has become clearer that the transmissibility of this virus is faster,” said senior health official Vinod Kumar Paul.

Vaccine demand has outpaced supply as the inoculation campaign widened this month, while companies struggle to boost output, partly because of a shortage of raw material and a fire at a facility making the AstraZeneca dose.

However, the federal government will not import vaccines itself but expects states and companies to do so instead, in a step aimed at backing domestic manufacturers, two government officials told Reuters. [L4N2MF3ZM]

Neighboring Bangladesh sealed its border with India for 14 days, its foreign ministry said, though trade will continue. Air travel has been suspended since Bangladesh imposed a lockdown on April 14 to combat record infections and deaths.

(Reporting by Shilpa Jamkhandikar and Neha Arora; Additional reporting by Sumit Khanna, Krishna Das, Anuron Kumar Mitra, Chandini Monnappa in Bengaluru, Rajendra Jadhav in Satara, Ruma Paul in Dhaka and Dmitry Antonov in Moscow; Writing by Clarence Fernandez and William Maclean; Editing by Simon Cameron-Moore and Gareth Jones)

Hospitals overrun as India’s COVID-19 infections top global record for second day

By Alasdair Pal and Neha Arora

NEW DELHI, (Reuters) -People scrambled for life-saving oxygen supplies across India on Friday and patients lay dying outside hospitals as the capital recorded the equivalent of one death from COVID-19 every five minutes.

For the second day running, the country’s overnight infection total was higher than ever recorded anywhere in the world since the pandemic began last year, at 332,730.

India’s second wave has hit with such ferocity that hospitals are running out of oxygen, beds and anti-viral drugs. Many patients have been turned away because there was no space for them, doctors in Delhi said.

Ambulance sirens sounded throughout the day in the deserted streets of the capital, one of India’s worst hit cities, where a lockdown is in place to try and stem the transmission of the virus.

Mass cremations have been taking place as the crematoriums have run out of space and families have had to wait for two days to cremate the dead.

At Guru Teg Bahadur Hospital in the north east of the city, critical patients gasping for air arrived in ambulances and autorickshaws. One man among half a dozen people waiting for hours on trolleys outside on Friday died before being admitted.

“The staff are doing their best but there is not enough oxygen,” Tushar Maurya, whose mother is being treated at the hospital, told Reuters. “If you are not in a serious condition please don’t come. It isn’t safe.”

ALL ALONE

The India Today television channel showed angry relatives outside a hospital in Ahmedabad, the largest city in Prime Minister Narendra Modi’s home state of Gujarat.

“People are dying in front of hospitals while they wait for a bed to become available,” one man said.

Another young man, who was not identified, said “Is this why we voted for this government? When we need it the most, we find ourselves all alone. Where will the poor go?”

Health experts say India became complacent in the winter, when new cases were running at about 10,000 a day and seemed to be under control, and lifted restrictions to allow big gatherings.

Modi himself has faced rare criticism for allowing political rallies and a Hindu religious festival, in which millions take a ritual bath in the Ganges river, to go ahead. He addressed many of the rallies with packed crowds and few people wearing masks.

“Indians let down their collective guard,” Zarir Udwadia, a pulmonologist on Maharashtra’s task force, wrote in the Times of India newspaper.

“We heard self-congratulatory declarations of victory from our leaders, now cruelly exposed as mere self-assured hubris.”

Delhi’s government declared in February it had beaten back the coronavirus. On Friday, Chief Minister Arvind Kejriwal went on live television to plead for medical oxygen supplies in a virtual meeting with Modi, warning that many people would die.

“All of the country’s oxygen plants should immediately be taken over by the government through the army,” he said.

Police in the northern state of Uttar Pradesh, some wielding assault rifles, escorted trucks to waiting hospitals in Delhi, while city governments traded accusations over hoarding.

Modi said government was making a “continuous effort” to increase oxygen supplies, including steps to divert industrial oxygen.

A fire broke out in a hospital treating COVID-19 patients in a Mumbai suburb early on Friday, killing 13 people, underlining the stress the hospitals were under. On Wednesday, 22 patients died at a public hospital in Maharashtra where Mumbai is located when oxygen supply ran out due to a leaking tank.

World Health Organization chief Tedros Adhanom Ghebreyesus said he was concerned about the growing case load in India, which on Thursday passed the previous global high of 297,430 recorded in January in the United States, where case numbers have fallen.

“The situation in India is a devastating reminder of what the virus can do,” he told a virtual briefing in Geneva.

WHO emergencies director Mike Ryan said reducing transmission would be a “very difficult task” but the government was working on limiting mixing between people, which he said was essential.

Bhramar Mukherjee, a professor of biostatistics and epidemiology at the University of Michigan in the United States, said it seemed as if there was no social safety net for Indians.

“Everyone is fighting for their own survival and trying to protect their loved ones,” he said. “This is hard to watch.”

(Additional reporting by Shilpa Jamkhandikar, Sachin Ravikumar, Devjyot Ghoshal, Aditya Kalra, Anuron Kumar Mitra, Nivedita Bhattacharjee, Stephanie Nebehay, Writing by Sanjeev Miglani and Richard Pullin; Editing by Robert Birsel, Clarence Fernandez and Philippa Fletcher)